Anne M. Hanna

Certified phlebotomist and Vanderbilt University undergraduate with extensive hands-on experience in blood sample collection and processing, flow cytometry, and clinical lab techniques. Skilled in liquid biopsy procedures and patient sample handling through research at Vanderbilt University Medical Center, with additional volunteer experience assisting nursing staff at the Vanderbilt Breast Center.

• Circulating Tumor Cell Dynamics in Prostate Cancer Patients Undergoing Pluvicto Therapy: Insights into Treatment Response and Disease Progression, Sarna N.S., Hanna A.M., Desai S.H., Hurley P.J., Schaffer K.R., King M.R., In Preparation
• From Stress to Strength: A Kinetic Study of Enhanced and Sustained T Cell Activation and Fitness via Fluid Shear Stress, Sarna N.S., Desai S.H., Kaufman B.G., Hanna A.M., King, M.R., 12/01/23

• Dr. Mona Mashayekhi, Assistant Professor of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, mona.mashayekhi@vumc.org
• Nicole S. Sarna, PhD Candidate, Biomedical Engineering, NSF Graduate Research Fellow, nicole.s.sarna@rice.edu
• Dr. Micheal R. King, E.D. Butcher Chair of Bioengineering & CPRIT Scholar, Special Advisor to the Provost on Life Science Collaborations with the Texas Medical Center, Rice University, mike.king@rice.edu

• Evaluating Immunologic Effects of GLP-1 Receptor Activation in Obesity, Poster, Translational Research Forum, Nashville, TN, 01/01/26
• Evaluating Immunologic Effects of GLP-1 Receptor Activation in Obesity, Poster, Vanderbilt Diabetes: Molecules to People Symposium, Nashville, TN, 01/01/25
• Evaluating Immunologic Effects of GLP-1 Receptor Activation in Obesity, Oral, SyBBURE Summer Symposium, Nashville, TN, 01/01/25
• Evaluating Circulating Tumor Cells (CTCs) in Prostate Cancer Patient Blood Samples Throughout Pluvicto Treatment, Poster, Vanderbilt University Undergraduate Research Fair, Nashville, TN, 01/01/24
• Evaluating Circulating Tumor Cells (CTCs) in Prostate Cancer Patient Blood Samples Throughout Pluvicto Treatment, Poster, SEMSS Conference, Nashville, TN, 01/01/24
• Evaluating Circulating Tumor Cells (CTCs) in Prostate Cancer Patient Blood Samples Throughout Pluvicto Treatment, Oral, Vanderbilt BME Summer in a Minute Competition, Nashville, TN, 01/01/23

• Undergraduate Research Assistant, Vanderbilt University Medical Center, Department of Medicine, Mashayekhi Lab, Nashville, TN, Mona Mashayekhi, MD, PhD, 11/01/24, Present, Lab focuses on the contribution of chronic inflammation in individuals with obesity to cardiometabolic diseases including heart disease and diabetes, Optimized a protocol to assess inflammation in patient samples from ELATE study, Applied flow cytometry and microscopy to quantify inflammation
• SyBBURE Research Fellow, Vanderbilt University, Nashville, TN, 06/01/24, 08/01/24
• Undergraduate Research Assistant, Vanderbilt University, Nashville, TN, Jonathan Brunger, PhD, Department of Biomedical Engineering, Hannah Brien, Department of Biomedical Engineering, 06/01/23, 05/01/24, Run PCRs to determine whether cloning of plasmids was successful
• High School Research Assistant, Vanderbilt University, Nashville, TN, Michael R. King, PhD, Department of Biomedical Engineering, Nicole S. Sarna, Department of Biomedical Engineering, Lab utilizes cellular engineering and drug delivery concepts to understand cancer metastasis and targeted immunotherapies, Evaluated the efficacy of prostate specific membrane antigen (PSMA) targeted therapy, Pluvicto, in late-stage metastatic prostate cancer patients, Isolated and analyzed primary circulating tumor cells (CTCs) from cancer patient blood samples, Performed confocal microscopy to identify CTC PSMA expression levels throughout the course of Pluvicto treatment